←Back to feed
🧠 AI🟢 BullishImportance 7/10
FROGENT: An End-to-End Full-process Drug Design Multi-Agent System
arXiv – CS AI|Qihua Pan, Dong Xu, Qianwei Yang, Jenna Xinyi Yao, Sisi Yuan, Zexuan Zhu, Jianqiang Li, Junkai Ji||3 views
🤖AI Summary
Researchers have developed FROGENT, an AI multi-agent system that uses large language models to automate the entire drug discovery pipeline from target identification to synthesis planning. The system outperformed existing AI approaches across eight benchmarks and demonstrated practical applications in real-world drug design scenarios.
Key Takeaways
- →FROGENT is a multi-agent system that automates end-to-end drug discovery processes using large language models for planning and coordination.
- →The system consists of four specialized agents including an orchestrator and three task-specific agents for retrieval, generation, and evaluation.
- →FROGENT outperformed six advanced ReAct-style agents across eight drug discovery benchmarks.
- →The system covers major drug discovery tasks including target identification, small-molecule generation, and peptide optimization.
- →This advancement could significantly reduce manual human intervention in pharmaceutical development workflows.
#ai#drug-discovery#multi-agent-systems#llm#pharmaceutical#automation#machine-learning#healthcare#research
Read Original →via arXiv – CS AI
Act on this with AI
Stay ahead of the market.
Connect your wallet to an AI agent. It reads balances, proposes swaps and bridges across 15 chains — you keep full control of your keys.
Related Articles